-
Loading metrics
Open Access
Study Protocol
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study
-
Jolien Van den Bossche ,
Roles Conceptualization, Funding acquisition, Methodology, Project administration, Writing – original draft
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliation Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium
⨯ -
Maxime De Laere ,
Roles Conceptualization, Funding acquisition, Methodology, Project administration, Visualization, Writing – original draft
* E-mail: Maxime.DeLaere@uza.be
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliations Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium, Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
⨯ -
Koen Deschepper ,
Roles Conceptualization, Investigation, Methodology, Resources, Writing – review & editing
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliation Division of Pulmonary and Infectious Diseases, VITAZ, Sint-Niklaas, Belgium
⨯ -
Paul Germonpré ,
Roles Conceptualization, Investigation, Methodology, Resources, Writing – review & editing
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliation Respiratory Oncology & Integrated Cancer Cancer Ghent, AZ Maria Middelares, Ghent, Belgium
⨯ -
Yvan Valcke,
Roles Investigation, Resources, Writing – review & editing
Affiliation Division of Pulmonary and Infectious Diseases, VITAZ, Sint-Niklaas, Belgium
⨯ -
Jan Lamont,
Roles Investigation, Resources, Writing – review & editing
Affiliation Respiratory Oncology & Integrated Cancer Cancer Ghent, AZ Maria Middelares, Ghent, Belgium
⨯ -
Barbara Stein,
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
Affiliation Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium
⨯ -
Kirsten Van Camp,
Roles Investigation, Project administration, Writing – review & editing
Affiliation Division of Pulmonary and Infectious Diseases, VITAZ, Sint-Niklaas, Belgium
⨯ -
Charlotte Germonpré,
Roles Investigation, Project administration, Writing – review & editing
Affiliation Respiratory Oncology & Integrated Cancer Cancer Ghent, AZ Maria Middelares, Ghent, Belgium
⨯ -
Griet Nijs,
Roles Project administration, Resources, Writing – review & editing
Affiliation Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium
⨯ -
Ella Roelant,
Roles Methodology, Software, Writing – review & editing
Affiliation Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital (UZA), University of Antwerp, Edegem, Belgium
⨯ -
Sébastien Anguille ,
Roles Funding acquisition, Resources, Writing – review & editing
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliations Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium, Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, Division of Hematology, Antwerp University Hospital (UZA), Edegem, Belgium
⨯ -
Eva Lion ,
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliations Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium, Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
⨯ -
Zwi Berneman
Roles Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing
¶‡ JVB, MDL, KD and PG share first authorship on this work. SA, EL and ZB are joint senior authors on this work.
Affiliations Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital (UZA), Edegem, Belgium, Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, Division of Hematology, Antwerp University Hospital (UZA), Edegem, Belgium
⨯
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study
- Jolien Van den Bossche,
- Maxime De Laere,
- Koen Deschepper,
- Paul Germonpré,
- Yvan Valcke,
- Jan Lamont,
- Barbara Stein,
- Kirsten Van Camp,
- Charlotte Germonpré,
- Griet Nijs
- Published: July 15, 2024
- https://doi.org/10.1371/journal.pone.0307204